Immunosuppressive Therapy Guidelines

Target Ranges and Regimens

The target tacrolimus range for renal-sparing regimens is 4-7 ng/mL when combined with other immunosuppressants, and 3-5 ng/mL when combined with other agents, as recommended by the Journal of Hepatology 1
For long-term maintenance, the target range for tacrolimus monotherapy is 4-6 ng/mL, with potential for lower levels if combined with other immunosuppressants, as suggested by the Journal of Hepatology 1

Patients at risk of post-transplant renal dysfunction should have lower trough levels targeted, initially 4-7 ng/mL and then 3-5 ng/mL 1
Delayed tacrolimus initiation (5 days post-transplant) with basiliximab induction and MMF/azathioprine is strongly recommended for liver transplant patients at risk of post-transplant renal dysfunction, as per the American Association for the Study of Liver Diseases 1

Combining tacrolimus with MMF, azathioprine, or mTOR inhibitors allows for lower tacrolimus targets while maintaining efficacy, as supported by the Journal of Hepatology and the American Journal of Transplantation 1, 2
Everolimus with reduced tacrolimus (trough 3-5 ng/mL) has shown improved renal function with comparable rejection rates compared to standard tacrolimus dosing, according to the American Journal of Transplantation 2
Delaying tacrolimus by 5 days prevents synergistic vasoconstrictive effects with perioperative risk factors for acute kidney injury, and introduces tacrolimus at reduced target levels (4-7 ng/ml) on day 5 onwards, with target levels of 3-5 ng/ml after the first month 1, 2

Monitoring of tacrolimus levels should be done daily until stable levels are achieved, then every 2-3 days until hospital discharge, and every 1-2 weeks during the first 1-2 months, as recommended by the American College of Chest Physicians 3
Trough levels should be drawn 12 hours after the last dose, immediately before the next scheduled dose, with consistent timing critical for accurate interpretation 4
Tacrolimus use is associated with an increased risk of hyperglycemia, hypertension, and nephrotoxicity, as reported by the American College of Chest Physicians 3
Drug interactions, genetic factors, food intake, liver function changes, and time post-transplant should be considered when monitoring tacrolimus levels 4
Early enteral nutrition within 24 hours post-transplant is recommended 5

Overimmunosuppression increases the risk of nephrotoxicity, neurotoxicity, and infections, while underimmunosuppression increases the risk of rejection, highlighting the importance of considering clinical context and laboratory parameters when interpreting levels 1, 2
Maintaining appropriate tacrolimus levels significantly impacts outcomes, and the target range of 6-10 ng/ml balances the need for adequate immunosuppression while minimizing nephrotoxicity, with lower levels of 4-8 ng/ml helping to preserve renal function while maintaining adequate immunosuppression 1